Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lynn M Heltemes-Harris

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Current Opinion in Immunology|February 21, 2012
The role of STAT5 in lymphocyte development and transformationLynn M Heltemes-Harris, Michael A Farrar
Nature Immunology|November 18, 2011
Turning transcription on or off with STAT5: when more is lessMichael A Farrar, Lynn M Heltemes Harris
Methods in Molecular Biology (Clifton, N.J.)|January 9, 2013
Constitutively active STAT5 constructsLynn M Heltemes-Harris, Michael A Farrar
Molecular Immunology|November 7, 2007
Activation-induced deaminase-mediated class switch recombination is blocked by anti-IgM signaling in a phosphatidylinositol 3-kinase-dependent fashionLynn M Heltemes-Harris, Patricia J Gearhart, Paritosh Ghosh, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 28, 2013
Cutting edge: IL-12 and type I IFN differentially program CD8 T cells for programmed death 1 re-expression levels and tumor controlMichael Y Gerner, Lynn M Heltemes-Harris, Brian T Fife, et al.
Annals of the New York Academy of Sciences|February 1, 2011
The role of STAT5 in the development, function, and transformation of B and T lymphocytesLynn M Heltemes-Harris, Mark J L Willette, Kieng B Vang, et al.
Nature Communications|November 26, 2021
Single-cell analysis identifies dynamic gene expression networks that govern B cell development and transformationRobin D Lee, Sarah A Munro, Todd P Knutson, et al.
Blood|March 11, 2022
Combining nilotinib and PD-L1 blockade reverses CD4+ T-cell dysfunction and prevents relapse in acute B-cell leukemiaSean I Tracy, Hrishi Venkatesh, Can Hekim, et al.
Nature Immunology|November 1, 2022
Nuclear corepressors NCOR1/NCOR2 regulate B cell development, maintain genomic integrity and prevent transformationRobin D Lee, Todd P Knutson, Sarah A Munro, et al.
Biorxiv : the Preprint Server for Biology|July 9, 2025
PDL1 CHECKPOINT BLOCKADE SYNERGIZES WITH NILOTINIB BUT NOT DASATINIB TO PREVENT LEUKEMIA RELAPSEElizabeth C Morgan, Hrishi Venkatesh, Enoc Granados Centenos, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Current Opinion in Immunology|February 21, 2012
The role of STAT5 in lymphocyte development and transformationLynn M Heltemes-Harris, Michael A Farrar
Nature Immunology|November 18, 2011
Turning transcription on or off with STAT5: when more is lessMichael A Farrar, Lynn M Heltemes Harris
Methods in Molecular Biology (Clifton, N.J.)|January 9, 2013
Constitutively active STAT5 constructsLynn M Heltemes-Harris, Michael A Farrar
Molecular Immunology|November 7, 2007
Activation-induced deaminase-mediated class switch recombination is blocked by anti-IgM signaling in a phosphatidylinositol 3-kinase-dependent fashionLynn M Heltemes-Harris, Patricia J Gearhart, Paritosh Ghosh, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 28, 2013
Cutting edge: IL-12 and type I IFN differentially program CD8 T cells for programmed death 1 re-expression levels and tumor controlMichael Y Gerner, Lynn M Heltemes-Harris, Brian T Fife, et al.
Annals of the New York Academy of Sciences|February 1, 2011
The role of STAT5 in the development, function, and transformation of B and T lymphocytesLynn M Heltemes-Harris, Mark J L Willette, Kieng B Vang, et al.
Nature Communications|November 26, 2021
Single-cell analysis identifies dynamic gene expression networks that govern B cell development and transformationRobin D Lee, Sarah A Munro, Todd P Knutson, et al.
Blood|March 11, 2022
Combining nilotinib and PD-L1 blockade reverses CD4+ T-cell dysfunction and prevents relapse in acute B-cell leukemiaSean I Tracy, Hrishi Venkatesh, Can Hekim, et al.
Nature Immunology|November 1, 2022
Nuclear corepressors NCOR1/NCOR2 regulate B cell development, maintain genomic integrity and prevent transformationRobin D Lee, Todd P Knutson, Sarah A Munro, et al.
Biorxiv : the Preprint Server for Biology|July 9, 2025
PDL1 CHECKPOINT BLOCKADE SYNERGIZES WITH NILOTINIB BUT NOT DASATINIB TO PREVENT LEUKEMIA RELAPSEElizabeth C Morgan, Hrishi Venkatesh, Enoc Granados Centenos, et al.
Pageof 2